Skip to main content
# Title Department Research Year
451 CK2 Inhibition, Lipophilicity and Anticancer Activity of New N1 Versus N2-Substituted Tetrabromobenzotriazole Regioisomers Department of Pharmaceutical Organic Chemistry 2020
452 Nanostructured Lipid Carriers to Mediate Brain
Delivery of Temazepam: Design and In Vivo Study
2020
453 Novel Class of Benzimidazole-Thiazole Hybrids: The Privileged Scaffolds of Potent Anti-Inflammatory Activity with Dual Inhibition of Cyclooxygenase and 15-Lipoxygenase Enzymes Department of Pharmaceutical Organic Chemistry 2020
454 Design, Synthesis and Biological Evaluation of Novel 5-((substituted quinolin-3-yl /1-naphthyl) methylene)-3-substituted imidazolidin-2,4-dione as HIV-1 Fusion Inhibitors Department of Pharmaceutical Organic Chemistry 2020
455 Pencil Graphite Electrode Decorated with Xylenol Orange Flakes for Studying Possible Pharmacokinetic Interaction Between Vardenafil and Daclatasvir Department of Pharmaceutical Analytical Chemistry 2020
456 Dual-recognition molecularly imprinted aptasensor based on gold nanoparticles decorated carboxylated carbon nanotubes for highly selective and sensitive determination of histamine in different matrices Department of Pharmaceutical Analytical Chemistry 2020
457 Cytotoxic Activity of Abietane-Type Diterpenes Isolated From Taxodium distichum Against Cancer Cells Adapted to Nutrient-Starved Conditions Department of Pharmacognosy 2020
458 Evaluation of autophagy-related genes in Egyptian systemic
lupus erythematosus patients
2020
459 Further Insight Into the Dual COX-2 and 15-LOX Anti-Inflammatory Activity of 1,3,4-Thiadiazole-thiazolidinone Hybrids: The Contribution of the Substituents at 5th Positions is Size Dependent Department of Pharmaceutical Organic Chemistry 2020
460 Combining acetyl salicylic acid and rofecoxib into novel oral tablets normalize platelet function with potential higher tolerability in patients with cardiovascular disorders 2020